Karyopherin α2 activators represent a diverse group of compounds with the shared function of enhancing karyopherin α2 gene expression. Despite differences in structure, these activators converge on stimulating karyopherin α2 transcription through distinct molecular strategies. Many karyopherin α2 activators mediate their effects by binding specific intracellular receptors. This triggers formation of receptor-cofactor complexes which target regulatory sequences in the karyopherin α2 promoter. Recruited cofactors then remodel chromatin configuration to improve recruitment of basal transcriptional machinery. Alternatively, certain activators mobilize intracellular signaling networks that modulate activities of DNA-binding transcription regulators.
Some activators may additionally exert indirect impacts by disrupting general cellular processes tied to controlling karyopherin α2 levels. Disturbance of homeostatic controls, stress pathways or epigenetic modifiers could secondarily influence the local milieu of transcriptional governance over karyopherin α2. Regardless of mechanism, all members of this group consistently function genomically to amplify karyopherin α2 mRNA and protein production across cell types. Characterization of their diverse activation strategies has advanced knowledge of transcriptional regulation governing this nucleocytoplasmic transporter.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
β-Estradiol forms ER complexes recruiting chromatin remodeling enzymes to the karyopherin α2 promoter, making it accessible for transcription initiation protein binding and enhanced mRNA synthesis. | ||||||
Angiotensin II, Human | 4474-91-3 | sc-363643 sc-363643A sc-363643B sc-363643C | 1 mg 5 mg 25 mg 100 mg | $51.00 $100.00 $310.00 $690.00 | 3 | |
Angiotensin II triggers EGFR transactivation of MAPKs. Modified ELK1 and other transcription factors then bind Ets sites within the karyopherin α2 promoter region to potentiate gene expression. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
VPA inhibits HDAC activity yielding chromatin remodeling changes allowing assembly of factor complexes at regulatory locations that activate karyopherin α2 gene transcription. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol induces SIRT1 activity altering histone acetylation signatures near the karyopherin α2 promoter, favoring binding of transactivator proteins to stimulate gene transcription. | ||||||